Phase I/II study of tecemotide cancer immunotherapy for Japanese patients with unresectable stage III non-small cell lung cancer (NSCLC).

被引：3
作者：
Nokihara, Hiroshi
Katakami, Nobuyuki
Hida, Toyoaki
Imamura, Fumio
Sakai, Hiroshi
Atagi, Shinji
Nishio, Makoto
Helwig, Christoph
Achiwa, Hiroyuki
Tamura, Tomohide
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
[3] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan
[4] Osaka Med Ctr, Osaka, Japan
[5] Saitama Canc Ctr, Saitama, Japan
[6] Kinki Chuo Chest Med Ctr, Osaka, Japan
[7] Japanese Fdn Canc Res, Tokyo, Japan
[8] Merck KGaA, Darmstadt, Germany
[9] Merck Serono Co Ltd, Tokyo, Japan
[10] St Lukes Int Hosp, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.3036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3036
引用
收藏
页数：1
相关论文
共 50 条
[31]   Concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase I study [J].
Cardenal, Felipe ;
Arnaiz, Ma Dolores ;
Moran, Teresa ;
Jove, Josep ;
Sole, Josep Ma ;
Porta, Ruth ;
Nadal, Ernest ;
Brao, Isabel ;
Palmero, Ramon ;
Fuentes, Rafael ;
Nunez, Inmaculada ;
Cassinello, Alejo .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) :S849-S849
[32]   Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508) [J].
Patel, Jyoti D. ;
Lee, Ju-Whei ;
Carbone, David P. ;
Wagner, Henry ;
Shanker, Anil ;
de Aquino, Maria Teresa P. ;
Horn, Leora ;
Johnson, Melissa L. ;
Gerber, David E. ;
Liu, Jane Jijun ;
Das, Millie S. ;
Al-Nsour, Mohammed Ali ;
Dakhil, Christopher S. R. ;
Ramalingam, Suresh ;
Schiller, Joan H. .
CLINICAL LUNG CANCER, 2020, 21 (06) :520-526
[33]   Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients [J].
Kazutaka Hosoya ;
Daichi Fujimoto ;
Hayato Kawachi ;
Yuki Sato ;
Mariko Kogo ;
Kazuma Nagata ;
Atsushi Nakagawa ;
Ryo Tachikawa ;
Shinya Hiraoka ;
Masaki Kokubo ;
Keisuke Tomii .
Cancer Chemotherapy and Pharmacology, 2019, 84 :275-280
[34]   Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer [J].
Mooradian, Meghan J. ;
Cai, Ling ;
Wang, Alice ;
Qiao, Yao ;
Chander, Pratibha ;
Whitaker, Ryan M. .
JAMA NETWORK OPEN, 2024, 7 (04)
[35]   PACIFIC: An Ocean of Hope in Patients With Stage III Unresectable Non-Small Cell Lung Cancer [J].
Uprety, Dipesh ;
Marinier, David E. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05) :458-460
[36]   Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients [J].
Hosoya, Kazutaka ;
Fujimoto, Daichi ;
Kawachi, Hayato ;
Sato, Yuki ;
Kogo, Mariko ;
Nagata, Kazuma ;
Nakagawa, Atsushi ;
Tachikawa, Ryo ;
Hiraoka, Shinya ;
Kokubo, Masaki ;
Tomii, Keisuke .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (02) :275-280
[37]   A Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Unresectable Stage III Non-Small Cell Lung Cancer [J].
Durm, Greg ;
Hanna, Nasser .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S569-S570
[38]   Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study [J].
Steward, WP ;
Dunlop, DJ ;
Cameron, C ;
Talbot, DC ;
Kleisbauer, JL ;
Thomas, P ;
Guerin, JC ;
Perol, M ;
Sanson, C ;
Dabouis, G ;
Lacroix, H .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :1081-1081
[39]   A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer [J].
Morse, MA ;
Garst, J ;
Osada, T ;
Khan, S ;
Hobeika, A ;
Clay, TM ;
Valente, N ;
Shreeniwas, R ;
Sutton, MA ;
Delcayre, A ;
Hsu, DH ;
Le Pecq, JB ;
Lyerly, HK .
JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
[40]   A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer [J].
Michael A Morse ;
Jennifer Garst ;
Takuya Osada ;
Shubi Khan ;
Amy Hobeika ;
Timothy M Clay ;
Nancy Valente ;
Revati Shreeniwas ;
Mary Ann Sutton ;
Alain Delcayre ;
Di-Hwei Hsu ;
Jean-Bernard Le Pecq ;
H Kim Lyerly .
Journal of Translational Medicine, 3
12345